# Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance), Division 4

Extent: E+W+S+N.I.

The efficacy of each of the components of multivalent and combined immunological veterinary medicinal products shall be demonstrated. If the product is recommended for administration in combination with or at the same time as another veterinary medicinal product, they shall be shown to be compatible.

---
Source: https://www.legislation.gov.uk/eur/2019/6/annex/II/title/II/chapter/II/division/A/division/4 (the official version)
Page: https://openlegislation.uk/eu-regulation-2019-6/annex-II/title-II/chapter-II/division-A/division-4
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.